Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
about
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms.Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
P2860
Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of (68)Ga-DOTA-TOC ...... tumors in patients with MEN1.
@en
type
label
Evaluation of (68)Ga-DOTA-TOC ...... tumors in patients with MEN1.
@en
prefLabel
Evaluation of (68)Ga-DOTA-TOC ...... tumors in patients with MEN1.
@en
P2093
P2860
P1476
Evaluation of (68)Ga-DOTA-TOC ...... tumors in patients with MEN1.
@en
P2093
Antoine Tabarin
Clément Morgat
Delphine Gaye
Delphine Vimont
Denis Smith
Elif Hindié
Fritz-Line Vélayoudom-Céphise
Joachim Mazère
Jürgen Schulz
Marie-Laure Nunes
P2860
P2888
P304
P356
10.1007/S00259-016-3319-3
P50
P577
2016-01-28T00:00:00Z